Amplify Weight Loss Drug & Treatment ETF (THNR)
NYSEARCA: THNR · Real-Time Price · USD
26.14
+0.12 (0.46%)
Nov 13, 2026, 4:00 PM EST - Market closed
THNR Holdings Information
THNR is an equity ETF with a total of 23 individual holdings. The top holdings are Eli Lilly and Company stock at 11.99%, Novo Nordisk at 8.71%, Amgen at 6.14%, Regeneron Pharmaceuticals at 6.04%, and AstraZeneca at 5.81%.
Total Holdings
23
Top 10 Percentage
66.15%
Asset Class
Equity
ETF Category
Health
Assets
5.20M
PE Ratio
22.43
Breakdown by Country
Top 25 Holdings
Updated Nov 12, 2026